Post-transplant recurrence of focal segmental glomerular sclerosis: consensus statements
Focal segmental glomerular sclerosis (FSGS) is 1 of the primary causes of nephrotic syndrome in both pediatric and adult patients, which can lead to end-stage kidney disease. Recurrence of FSGS after kidney transplantation significantly increases allograft loss, leading to morbidity and mortality. Currently, there are no consensus guidelines for identifying those patients who are at risk for recurrence or for the management of recurrent FSGS. Our work group performed a literature search on PubMed/Medline, Embase, and Cochrane, and recommendations were proposed and graded for strength of evidence.
Source: Kidney International - Category: Urology & Nephrology Authors: Rupesh Raina, Swathi Jothi, Dieter Haffner, Michael Somers, Guido Filler, Prabhav Vasistha, Ronith Chakraborty, Ron Shapiro, Parmjeet S. Randhawa, Rulan Parekh, Christopher Licht, Timothy Bunchman, Sidharth Sethi, Guneive Mangat, Joshua Zaritsky, Franz Sc Tags: Meeting Report Source Type: research
More News: Bone Graft | Kidney Transplant | Kidney Transplantation | Nephrotic Syndrome | Nutrition | Pediatrics | Transplant Surgery | Transplants | Urology & Nephrology